Ophthotech amends IPO

Ophthotech Corp. (New York, N.Y.) again amended its IPO and now plans to sell 7.6 million shares at $19-$20. At the $19.50 midpoint, the company would raise $148.2 million and be valued at $587.2 million. Morgan Stanley; JPMorgan; Leerink; and Stifel are underwriters. Earlier this month, Ophthotech amended the IPO to sell 5.7 million shares at $16-$19. At the $17.50 midpoint, the company would have raised $100.1 million and been valued at $494 million. Last month, Ophthotech filed to raise up to $85 million in the offering. ...